Global Qi-Tonifying Chinese Medicine Injections Market Growth 2025-2031

The global Qi-Tonifying Chinese Medicine Injections market size is predicted to grow from US$ 115 million in 2025 to US$ 147 million in 2031; it is expected to grow at a CAGR of 4.1% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Qi-Tonifying Chinese Medicine Injections are sterile formulations developed from traditional herbs known for replenishing Qi, produced using modern pharmaceutical techniques. They are primarily used in clinical cases involving Qi deficiency, such as during recovery from chronic illness or in patients with weakened immunity. These injections are valued for their fast-acting effects and suitability for patients unable to take oral medications. However, challenges remain, including unclear mechanisms of active ingredients, insufficient clinical validation, and the potential for overuse, emphasizing the need for rigorous re-evaluation and standardized clinical practices.

United States market for Qi-Tonifying Chinese Medicine Injections is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Qi-Tonifying Chinese Medicine Injections is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Qi-Tonifying Chinese Medicine Injections is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Qi-Tonifying Chinese Medicine Injections players cover Suzhong Pharmaceutical Group, China Resources Sanjiu, Changshu Leiyunshang Pharmaceutical, Sinopharm Yibin Pharmaceutical, Shineway Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Qi-Tonifying Chinese Medicine Injections Industry Forecast” looks at past sales and reviews total world Qi-Tonifying Chinese Medicine Injections sales in 2024, providing a comprehensive analysis by region and market sector of projected Qi-Tonifying Chinese Medicine Injections sales for 2025 through 2031. With Qi-Tonifying Chinese Medicine Injections sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Qi-Tonifying Chinese Medicine Injections industry.

This Insight Report provides a comprehensive analysis of the global Qi-Tonifying Chinese Medicine Injections landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Qi-Tonifying Chinese Medicine Injections portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Qi-Tonifying Chinese Medicine Injections market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Qi-Tonifying Chinese Medicine Injections and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Qi-Tonifying Chinese Medicine Injections.

This report presents a comprehensive overview, market shares, and growth opportunities of Qi-Tonifying Chinese Medicine Injections market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Shengmai Injection
Astragalus Injection
Other

Segmentation by Application:
Secondary Hospital
Tertiary Hospital
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Suzhong Pharmaceutical Group
China Resources Sanjiu
Changshu Leiyunshang Pharmaceutical
Sinopharm Yibin Pharmaceutical
Shineway Pharmaceutical
Chiatai Qingchunbao Pharmaceutical
ZBD Pharmaceutical
Jilin Jian Yisheng Pharmaceutical
Dali Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Qi-Tonifying Chinese Medicine Injections market?

What factors are driving Qi-Tonifying Chinese Medicine Injections market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Qi-Tonifying Chinese Medicine Injections market opportunities vary by end market size?

How does Qi-Tonifying Chinese Medicine Injections break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver. Show more